Remoxipride en es it fr

Remoxipride Brand names, Remoxipride Analogs

Remoxipride Brand Names Mixture

  • No information avaliable

Remoxipride Chemical_Formula


Remoxipride RX_link

No information avaliable

Remoxipride fda sheet

Remoxipride msds (material safety sheet)

Remoxipride Synthesis Reference

No information avaliable

Remoxipride Molecular Weight

371.269 g/mol

Remoxipride Melting Point

No information avaliable

Remoxipride H2O Solubility

74 mg/L

Remoxipride State


Remoxipride LogP


Remoxipride Dosage Forms


Remoxipride Indication

For the treatment of schizophrenia.

Remoxipride Pharmacology

Remoxipride, a substituted benzamide, is a selective D2 receptor antagonist. It has been shown to be effective in the treatment of schizophrenia. Some antipsychotics block domapinergic receptors as well as cholinergic, noradrenergic and histaminergic receptors. Remoxipride was developed to act specifically on the dopamine D2 receptor. As a consequence, several undesired side effects can occur. Patients often feel they are not taking any antipsychotic drug. It has a potent affinity for the sigma receptor, but it is unclear whether it is a sigma agonist or antagonist. The contribution of this property to its clinical profile is unknown. Blocking the D2 dopamine receptor is known to cause relapse in patients that have achieved remission from depression, and such blocking also counteracts the effectiveness of SSRI medication.

Remoxipride Absorption

Rapidly absorbed. Absolute bioavailability is 90%.

Remoxipride side effects and Toxicity

No information avaliable

Remoxipride Patient Information

No information avaliable

Remoxipride Organisms Affected

Humans and other mammals